In the field of 1,3-PD bioproduction, there are many bottlenecks. Firstly, in the reductive branch of glycerol dissimilation, the synthesized intermediary compound 3-HPA is toxic to the bacteria and can prevent their growth. It has been widely applied as biological sterilization agent and anti-infection treatment agent. The exact mechanism is not very clear now (30). Besides, the two key enzymes of the branch, GDHt and PDOR are both susceptible to high concentrations of 3-HPA, which lowers their activity. As a result, the production of toxic 3-HPA in the culture media is triggered by a positive feedback mechanism, i.e. the increase of 3-HPA will repress the activity of GDHt in order to decrease the harmful effect of the toxicant. Hence, the decreased intermediates cause a low titre of the target product. This process triggers irreversible cessation of metabolic activity, which becomes a serious limitation to the 1,3-PD production process (31).

Secondly, the accumulation of 1,3-PD itself also inhibits cellular growth. Szymanowska-Powałowska and Kubiak (32) tested the effect of 1,3-PD in C. butyricum DSP1. 1,3-PD was added to the medium at the beginning of the cultivation prior to inoculation. The results showed that relatively high activity of the analyzed strain was maintained up to a concentration of 1,3-PD of 60 g/L. When exogenous 1,3-PD was added at an initial concentration of 80 g/L, it was lethal to the bacteria. Colin et al. (33) also studied the inhibitory effect of 1,3-PD in C. butyricum CNCM 1211. In their study, the tolerance levels were similar, and they discussed that the particular inhibitory effect of 1,3-PD was not related to osmotic pressure but rather to a modification of membrane organization by an increase in the fluidity of the membrane, causing the ethanol inhibition in microbial fermentation.

Finally, byproduct formation and maintaining redox balance is another bottleneck of 1,3-PD production. As shown in Fig. 1, in the metabolic pathway of glycerol, many kinds of other metabolites apart from 1,3-PD are generated simultaneously, becoming the byproducts of 1,3-PD production. In the oxidative branch, glycerol is transformed to phosphoenolpyruvate (PEP) through several steps catalyzed by some ATP-dependent oxidoreductases. For the mainstream metabolic pathway glycolysis, glucose is also transformed to PEP. Then PEP is catalyzed by pyruvate kinase to pyruvate, which fluxes to byproduct formation. Many factors can affect this process, such as external and genetic conditions. As a consequence, both quality and quantity of the byproducts are affected (28). Carbon from glycerol or glucose is consumed during the formation of these byproducts, resulting in a decrease in the titre of target product. Some of these byproducts are also toxic to the cells, inhibiting their growth. Therefore, the deletion of genes which cause the formation of these byproducts should be a good solution. However, these multiple pathways can adjust the balance of intracellular redox, i.e. the redox potential should be kept to stabilize the proteins when deleting these relative genes. The formation of unnecessary metabolites should be avoided and the balance of redox should be maintained. This is a challenge for the improvement of the product (34).

So far, researchers have attempted to debottleneck various steps of bioprocesses, and some progress has been made, but further attention should be paid to achieve more desired effects.

The dhaD gene encodes the NAD⁺-linked glycerol dehydrogenase (GDH). GDH catalyzes the oxidation from glycerol to DHA. Furthermore, enzyme DHAK encoded by dhaK gene catalyzes the phosphorylation from DHA to DHAP. This is the first step of oxidation branch (24). During the biological production of 1,3-PD, the formation of byproducts increases the purification cost and time. In particular, similar boiling points of 2,3-BD and 1,3-PD make purification much more difficult. One solution is to inactivate the two genes associated with DHA and DHAP. Horng et al. (23) inactivated the dhaD and dhaK by genetic engineering strategy to prevent the byproduct accumulation during 1,3-PD production in K. pneumoniae. The mutant strain TC100 deficient in GDH activity was generated by insertion-deletion of a streptomycin resistance marker into the dhaD-dhaK genes. The byproducts such as lactate, 2,3-BD and ethanol were not detected when this mutant was used for fermentation. The bacterial cells were cultured in 50-mL flasks and incubated at 37 °C. The yield of 1,3-PD by TC100 was increased by about 2.06 times compared to the wild type strain after 48 h of incubation. However, this mutant produced less biomass and had smaller productivity of 1,3-PD than the parent strain, so the production was optimized by gene overexpression (mentioned below) and incubation conditions were adjusted to solve this problem.

Total elimination of byproduct formation in the oxidative branch decreases the biomass. In return, the decreased biomass affects the reductive branch of glycerol dissimilation pathway, resulting in the decrease of 1,3-PD yield. The reason is that in the glycerol dissimilation pathway, the formation of byproducts in the oxidative branch provides reductive power for 1,3-PD synthesis (34). The problem that total elimination causes low 1,3-PD yield can also be solved by disconnecting the production and growth pathways. Maervoet et al. (35) studied the 1,3-PD production of Citrobacter werkmanii. Genetic tools were used to create C. werkmanii DSM 17579 ∆dhaD, in which dhaD gene was deleted. The mutant strain used glucose and glycerol to increase the biomass. As a result, the 1,3-PD yield on glycerol was improved 1.5 times.

Lactate is one of the byproducts of the reduction of pyruvate, which requires one molecule of NADH. It is a major byproduct in glycerol fermentation shunting the carbon flow away from pyruvate and leading to the decrease of 1,3-PD yield (26). During cell growth, lactate is accumulated in the late exponential phase, which prevents cellular growth. Therefore, many researchers have obtained lactate-deficient mutants so far to prevent the synthesis of lactate, which is of great significance for 1,3-PD fermentation (36-38). The concrete practice is knocking out the ldhA gene encoding lactate dehydrogenase. In addition, 2,3-BD is another main byproduct of the reduction of pyruvate in glycerol-based fermentation. As 2,3-BD is also a diol like 1,3-PD, they have similar boiling points and 1,3-PD is very hydrophilic (37). Therefore, this causes a serious obstacle to efficiently separate highly pure 1,3-PD from 2,3-BD. Naturally, the deletion of genes associated with 2,3-BD is a good idea to change this phenomenon and decrease the cost of purification.

Durgapal et al. (38) examined the ability of K. pneumoniae J2B to produce 1,3-PD from glycerol. In their study, a lactate dehydrogenase-deficient mutant was constructed. The wild type and ∆ldhA mutant strain were grown and compared under different culture conditions and different cultivation mode (batch or fed-batch). When K. pneumoniae ∆ldhA was cultivated in glycerol fed-batch mode, a promising result was obtained: the titre of 1,3-PD was 58.0 g/L with a yield of 0.35 g/g and an overall volumetric productivity of 1.3 g/(L·h). The analysis of carbon balance suggested that the ∆ldhA mutant strain produced negligible lactate but more 2,3-BD than wild strain. 2,3-BD became the main byproduct (the titre was 26.6 g/L) and less than 10 g/L of the other metabolites was detected. Therefore, in the following study (43) they deleted the 2,3-BD pathway genes, budA, budB, budC and budO (whole-bud operon) of K. pneumoniae J2B ∆ldhA. The result showed that the strain ∆budO eliminated 2,3-BD production completely but generated less 1,3-PD. It was shown that the accumulation of a significant amount of pyruvate is probably responsible for the decrease of 1,3-PD production. Some other research groups (40-42) also paid attention to the deletion of both ldhA gene and genes associated with 2,3-BD, such as als gene encoding acetolactate synthase in the biosynthesis of 2,3-BD. Oh et al. (44) focused on the mutants of K. pneumoniae with deletions of the als and ldhA genes. However, when using the mutants for producing 1,3-PD in the fed-batch fermentation, only the ∆ldhA strain was able to produce the maximum 1,3-PD (102.7 g/L).

Not only does the carbon flow from pyruvate to lactate, but it also flows to acetyl-CoA. As a result, many byproducts are produced. In the metabolic process of pyruvate, catalyzed by aldehyde dehydrogenase, acetyl-CoA is a significant mid-product. Afterwards, acetyl-CoA is reduced to other metabolites like acetate, ethanol and butyrate (22). Many kinds of mutants which are deficient in these byproducts have been developed (20, 36).

Acetate is an inhibitory metabolite to cellular growth. Among these metabolites from acetyl-CoA, acetate is the most toxic (26). Therefore, elimination of acetate synthesis is the most significant target in metabolic engineering of 1,3-PD production. Lin et al. (37) studied the effects of deletion of the genes poxB encoding pyruvate oxidase, pta encoding phosphotransacetylase and ackA encoding acetate kinase on cell growth and 1,3-PD yield of K. pneumoniae. These genes are all involved in the two main acetate synthesis pathways. The final 1,3-PD titre in the fed-batch fermentation reached 76.8 g/L, which was 15% higher than that of wild strain. These deletions severely decreased the formation of acetate and more carbon flowed to TCA cycle, and as a result the production of 1,3-PD was enhanced.

Ethanol is another key competitor to the formation of 1,3-PD (39). The formation of ethanol begins with the transformation from acetyl-CoA to acetaldehyde catalyzed by aldehyde dehydrogenase (encoded by aldH). Then, with catalyzed ethanol dehydrogenase (encoded by adhE), acetaldehyde is reduced to ethanol. This process needs four molecules of NADH. NADH acts as co-enzyme in the formation of ethanol, decreasing the quantity of NADH in reductive branch (28). The elimination of lactate combined with ethanol synthesis is also a promising method. In order to improve 1,3-PD production by K. pneumoniae, Chen et al. (36) deleted the relative genes and obtained K. pneumoniae 2-1∆ldhA, K. pneumoniae 2-1∆aldH and K. pneumoniae 2-1∆ldhA∆aldH mutant strains. In a fed-batch culture, the production of 1,3-PD from glycerol was enhanced and the concentrations of byproducts were reduced compared with the original strain K. pneumoniae 2-1. The maximum titres of 1,3-PD were 85.7, 82.5 and 87.5 g/L compared with 78.8 g/L of the parental strain. Maervoet et al. (20) deleted the gene adhE singly, doubled with dhaD, and tripled with dhaD and ldhA in C. werkmanii. The single knockout showed that the yield of 1,3-PD was 0.7 mol/mol glycerol, while the yield obtained by the use of wild strain was 0.63 mol/mol. The result of double knockout was 0.96 mol/mol and of triple knockout was 1.0 mol/mol. The most promising result was that the maximum theoretical yield of 1.00 mol/mol glycerol and a final titre of (107.20±4.2) mmol/L 1,3-PD was reached when grown in shake flasks with glucose and glycerol as carbon sources under anaerobic conditions (20).

In the reductive branch of glycerol dissimilation, the two key enzymes, GDHt and PDOR, are encoded by dhaB and dhaT, respectively. As a result, the activity of the two enzymes can be enhanced and 1,3-PD yield can be increased as well. In addition, the enzyme PDOR is NADH-dependent (24). When the byproduct pathways were deleted, the intracellular redox balance (NADH/NAD⁺) was extremely high in these mutants, which has already been confirmed by some researchers. Therefore, these groups investigated further how to overexpress genes dhaB and dhaT to use these saved NADH (46, 48).

In the study of Cui et al. (40), the dhaT gene was overexpressed in two mutants of K. pneumoniae, KG1-3T (blocking of the 2,3-butanediol pathway only) and KG1-5T (blocking of both 2,3-BD and lactate pathways). The results showed that in KG1-5T, the redox balance was restored to normal and 1,3-PD yield was enhanced. The yield of 1,3-PD from glycerol in KG1-5T was restored to the normal level of 0.6. Oh et al. (42) first obtained a mutant of K. pneumoniae without the byproduct formation by deleting the oxidative branch of glycerol. Then, they studied the overexpression of the dhaB and/or dhaT genes in this mutant to improve the 1,3-PD yield. The results suggested that the mutant overexpressing dhaT alone gained the highest yield of the three mutants. In fed-batch fermentation, efficient production of 1,3-PD from either pure or crude glycerol was gained and no byproducts were formed.

Many researchers are seeking other methods that do not focus on the original 1,3-PD pathway. One of them is to clone the genes encoding the enzymes involved in the 1,3-PD synthesis pathway found in other natural strains of bacteria (49). Heterologous recombinant strains can also be constructed by metabolic engineering. These genes are expressed and isozymes are obtained for 1,3-PD fermentation. For example, yqhD gene from E. coli can encode an oxidoreductase which was found to possess the same function as PDOR from K. pneumoniae, and was thus considered as 1,3-PD oxidoreductase isoenzyme (PDORI) (32). Many researchers investigated this gene and cloned it into 1,3-PD producers to increase the yield. Zhu et al. (39) used a K. pneumoniae mutant with overexpression of PDORI, which surprisingly led to higher 1,3-PD production. The final 1,3-PD concentration of recombinant K. pneumoniae reached 67.6 g/L, which was 125.33% of that by the parent strain and the yield reached 0.62 mol/mol. The conversion activity of the enzyme in the recombinant mutant was detected. The maximum was increased 10-fold compared with the wild strain under the same conditions. Besides, the concentration of the toxic intermediate 3-HPA was reduced by 22.4% when compared to the original strain. Therefore, the overexpression of genes can also solve the inhibitory problem posed on the cell growth by the intermediary metabolite 3-HPA in the reductive branch of glycerol dissimilation.

Another method to decrease the concentration of 3-HPA during 1,3-PD fermentation is to convert 3-HPA to other metabolites (42). For example, the gene of an NAD⁺-dependent γ-glutamyl-γ-aminobutyraldehyde dehydrogenase (PuuC) of K. pneumoniae can be overexpressed. This enzyme is able to oxidize 3-HPA to 3-hydroxypropionic acid (3-HP). In that study puuC gene was cloned and overexpressed in K. pneumoniae DSM 2026 ∆dhaT (41). The recombinant puuC gene mutant can successfully produce 3.6 g/L of 3-HP in shake flask culture. In fed-batch fermentation, the recombinant K. pneumoniae ∆dhaT (puuC) strain produced 16.0 g/L of 3-HP and 16.8 g/L of 1,3-PD. The yield in 24 h reached 0.51 mol per mol of glycerol.

As it is mentioned above, in order to gain better producers, the inactivation or overexpression of more than one gene can be carried out. Besides, knocking out the genes encoding the production of byproducts and overexpressing useful genes simultaneously can give different advantages. Some other new biotechnology tools like genome shuffling, which can also be combined with inactivation or overexpression, could probably make the producers more efficient. Due to the modification of gene or even the genome, there are some limitations of these methods, for example, metabolic disorders may occur. These joint methods and related problems deserve attention in the future (26).

Ultraviolet radiation is a simple and effective method of mutagenesis, and the effective UV wavelength for treatment is 200-300 nm. Among these wavelengths, 254 nm is the optimum one, because it is the maximum absorption of nucleic acid. Ultraviolet radiation can cause base transitions, transversions, frameshift, mutation or deletion, resulting in the formation of mutants (56, 57). Most researchers (50, 54) had accomplished the UV mutagenesis of strains producing 1,3-PD directly by ultraviolet lamp irradiation. The distance, time and power of UV irradiation can affect the mutagenesis ratio. The UV parameters were investigated at different levels, and the appropriate level was determined by the mortality rate. The optimal mortality rate should be 90-95% (58). Afterwards, the selected parameters were used to make mutants and the ideal mutants were screened. By this pattern, Lu et al. (50) chose K. pneumoniae as the focus of their research, in which UV mutagenesis of its protoplast was induced, in order to improve the tolerance of the strain to glycerol and 1,3-PD, and thus to obtain strains with high 1,3-PD production. Two methods were designed to obtain the protoplast of K. pneumoniae. The samples were pretreated with glycine and then dissolved with lysozyme. After the mutagenesis of protoplasts, three high-yield strains (pK-1, K-4 and K-5) were obtained because of their tolerance to high concentration of glycerol and 1,3-PD. In fed-batch fermentation experiments, the 1,3-PD titres of pK-1, K-4 and K-5 were 70.24, 65.21 and 75.51 g/L, respectively. Compared with the wild strain, whose production was 55.78 g/L, the 1,3-PD production of mutant strains was improved by 25.92, 16.91 and 35.37%, respectively. As a very common physical mutagen, ultraviolet radiation is always combined with other chemical mutagens to obtain better producers.

Atmospheric pressure cold plasma is a non-equilibrium plasma at low temperature, which is the plasma at atmospheric pressure when gas is ionized by the influence of external high energy, i.e. high voltage, strong magnetic field, radiation, etc. Gas can produce a large number of active substances in the ionization process, including charged particles, metastable substances with chemical activity, such as ozone, activated hydroxyl radicals, oxygen atoms, and ultraviolet photon (59). These substances can interact with biological molecules and organisms like enzymes and DNA. Plasma can cause oxidative damage of DNA, leading to the damage of DNA double chain structure and to the death or mutation of organisms (60).

So far, the use of dielectric barrier discharge (DBD) plasma mutagenesis on 1,3-PD production has been reported (51). Dong et al. (61) used this method to evaluate K. pneumoniae strain with the capacity of producing 1,3-PD. Fig. 3 shows the diagram of DBD device they used, consisting of power supply and reactor. The reactor consists of a pair of circular aluminium plate electrodes covered with quartz glass. The cell suspension can be spread on the quartz glass and then treated with DBD plasma.

DBD plasma was used as a single mutagenesis agent and a stable strain of K. pneumoniae (designated Kp-M2) was generated with improved 1,3-PD production. The strain was obtained by exposing the cells to DBD plasma before subjecting them to fermentation with glycerol as a carbon source. In batch fermentation, Kp-M2 strain grew faster and consumed glycerol more rapidly than the wild type. The final yield of 1,3-PD was enhanced by 23%. In fed-batch fermentations, Kp-M2 also showed faster growth than wild type. Furthermore, in another work (51), a complex treatment of plasma and LiCl was attempted, and a mutant strain designated KpM30 was obtained in a medium containing FeCl₃ with selective pressure. The mutant showed a high titre of 1,3-PD (70.2 g/L, increased by 24.9% compared with the wild strain), and its yield on glycerol was 0.576 mol/mol, increased by 17.7% in fed-batch fermentation. Briefly, DBD plasma has antibacterial activity, the biological effect of improving seed vigour, as well as the unique potential of mutagenesis (62).

So far, there have been many other new physical mutagenesis means applied to microbial breeding, and good results have been achieved (63). For example, mutants can be obtained by the X-ray, neutron, ion implantation, microwave, ultrasonic or laser radiation, cosmic rays, etc. C. beijerinckii is used for butanol fermentation from a non-detoxified hemicellulosic hydrolysate of corn fibre treated with diluted sulfuric acid (SAHHC). This fermentation has similar bottlenecks in 1,3-PD production, i.e. both the substrate inhibitor and the product inhibitor. Therefore, in order to overcome these disadvantages, low-energy ion implantation technology was introduced to butanol fermentation. Guo et al. (64) used this technology to carry out the reconstruction of C. beijerinckii. As a result, they obtained mutant IB4, which had a high level of tolerance to the inhibitor. However, until now there have been few reports about the application of these new mutagenesis methods in the transformation of glycerol to 1,3-PD. The above examples can provide references for improving the tolerance of 1,3-PD and improving its yield.

Lithium chloride (LiCl) is an alkali metal halide, which has no direct mutagenic effect by itself, but when combined with other mutagens, it often has good synergistic mutagenic activity (65). LiCl is usually used in combination with UV mutagenesis in breeding. Du et al. (52) obtained mutants by UV light and LiCl mutagenesis derived from the parent strain of K. pneumoniae. In this study, a novel redox potential (oxidoreduction potential [ORP])-based screening strategy was designed for the isolation of mutants with high 1,3-PD production. LiCl was added to Luria-Bertani (LB) culture medium plates at a concentration of 2 g/L. Then the cell suspension in exponential growth phase was spread on these plates, which were put 40 cm below the UV light source (30 W) for 30 s. Under the above conditions, approx. 5 out of 100 cells survived. 1,3-PD was measured by high-performance liquid chromatography after incubation at 37 °C in the dark for 48 h. The highest 1,3-PD concentration of the mutant was 915 mM, i.e. 69.54 g/L, which was 63.1% higher than that of the wild strain. The distribution of metabolic flux analysis of this mutant indicated that the strengthened bioreductive branch contributed to the improved production of 1,3-PD. Wang et al. (54) also chose LiCl combined with other physicochemical agents to induce K. pneumoniae mutagenesis. Based on ion ray, ultraviolet light and LiCl mutation methods, product tolerance was increased, and as a result of that the conversion ability of glycerol into 1,3-PD also increased. Compared with parent strain, the production of the two mutants LM03 and LM05 was improved by 33 and 30% respectively. A large number of studies suggests that the rate of positive mutation by LiCl is much higher than the single UV mutagenesis, and protoplast mutagenesis by UV combined with LiCl is more liable than mycelium mutagenesis to obtain the high yield strains (52, 58, 65, 66).

N-methyl-N’-nitro-N-nitrosoguanidine (NTG) is an alkylating mutagenesis agent, which is a commonly used chemical mutagen. Many researchers focusing on NTG mutagenesis have found that NTG makes a strong preference for G/C to A/T transitions (63). In 1995, NTG was used for the mutagenesis of C. butyricum with the purpose of decreasing the substrate and product inhibition (67). In fed-batch culture, 44% more glycerol was consumed and 50% more 1,3-PD was produced by the mutant than by the wild type strain. Otte et al. (53) also used NTG as mutagen to enhance the yield of 1,3-PD by C. diolis DSM 15410 in a single-cell suspension. The cells were first treated with NTG solution for over 1 h at 34 °C, then centrifuged and resuspended. Finally, they were spread onto agar plates containing different concentrations of 1,3-PD for tolerance screening, and higher yield producers, mutant 44 and 46, were obtained. Combined with genome shuffling (directed evolution of whole organisms via recursive recombination at the genome level), an excellent producer with a 1,3-PD yield of 85 g/L was obtained, which is 80% higher than that of the parental wildtype strain.

Diethyl sulfate (DES) is another widely used alkylating mutagenesis agent. Using C. butyricum 209 as the original strain, Li et al. (55) obtained a mutant strain whose 1,3-PD yield was increased to 113% by two rounds of DES mutagenesis. UV mutagenesis alone and UV combined with NTG mutagenesis of this mutant were both carried out. 1,3-PD titre of the final mutant reached 15.7 g/L, 6.13 times higher than the original strain (the titre was 2.2 g/L). They used the single cell suspension method. Solid crystal can also be used in random chemical mutagenesis. A crystal of mutagen was placed at the centre of each plate. Two plates without the mutagen were used as the control. After several minutes, liquid strain culture was spread on each plate, which were then incubated until bacterial growth was observed (68).

There are just a few simple physical agents used currently for the conventional mutagenesis. Technologies like atmospheric and room temperature plasma have been used to produce new strains, and good results were obtained (52). Therefore, complex agents or other violent factors are a promising choice. In summary, these conventional mutagenesis methods provide good choices to obtain high-productivity industrial strains or express a particular phenotype. Moreover, some disadvantages are also obvious. For example, these methods are random, and the mutation rate is much lower than when using genetic methods. High throughput screening should be used to isolate the positive strains, which enlarges the working capacity. Therefore, proper attention should be paid to more efficient screening methods.